TABLE 1.
Differential susceptibilities of human cells to infection with FeLV-B
| Phenotypea | Cell lineb | Origin |
|---|---|---|
| Fully permissive | HEK293 | Adenovirus-transformed immortalized human embryonic kidney cells |
| MCF7* | Mammary carcinoma | |
| MDA-MB-231* | Mammary carcinoma | |
| HT29* | Colon carcinoma | |
| SW-620* | Colon carcinoma | |
| A549* | Lung carcinoma | |
| DU-145* | Prostate carcinoma | |
| PC-3* | Prostate carcinoma | |
| HT-1080 | Fibrosarcoma | |
| TKCC6 | Pancreatic carcinoma | |
| TKCC10 | Pancreatic carcinoma | |
| TKCC27LO | Pancreatic carcinoma | |
| MiPaCa2S | Pancreatic carcinoma | |
| Panc10.02 | Pancreatic carcinoma | |
| IMR90 | Nonimmortalized lung fibroblasts | |
| HaCAT | Immortalized skin keratinocytes | |
| Partially permissive | KYO-1 | Myeloid leukemia |
| CD34+ | Cord blood hematopoietic precursor | |
| HeLa* | Cervical carcinoma | |
| TKCC7 | Pancreatic carcinoma | |
| TKCC9 | Pancreatic carcinoma | |
| TKCC14 | Pancreatic carcinoma | |
| TKCC15LO | Pancreatic carcinoma | |
| MALME3M* | Melanoma | |
| Hs68 | Primary foreskin fibroblasts | |
| Nonpermissive | Reh | B-cell leukemia |
| UACC-62* | Melanoma | |
| PEO1 | Ovarian carcinoma | |
| OVCAR-4* | Ovarian carcinoma | |
| RCC4 | Renal carcinoma |
a
Defined according to a dilution/spread assay (Fig. 1C).
b
Asterisks indicate NCI-60 panel cell lines.